Skip to content

Clinical trials

Completed Non-alcoholic Fatty Liver Disease trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Completed Country / region: Austria Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20161
20171
20191
20213
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S2
AstraZeneca1
Boehringer Ingelheim1
German Diabetes Center1
Hoffmann-La Roche1
Inventiva Pharma1
Medical University of Vienna1
Merck Sharp & Dohme LLC1
Phenex Pharmaceuticals AG1
RWTH Aachen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease12
Fatty Liver3
Digestive System Diseases2
Atherosclerosis1
Cardiovascular Diseases1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Fibrosis1
Headache1
Hypertension1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.